The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Matt Larew is an analyst at William Blair. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/07/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 07/01/2024 | AMED | Buy Now | Amedisys | $97.21 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/10/2024 | DNA | Buy Now | Ginkgo Bioworks Holdings | $0.34 | — | — | Downgrade | Market Perform → Underperform | Get Alert |
| 04/29/2024 | ATR | Buy Now | AptarGroup | $141.51 | — | — | Upgrade | Market Perform → Outperform | Get Alert |
| 08/28/2023 | TECH | Buy Now | Bio-Techne | $71.56 | — | — | Initiates | → Outperform | Get Alert |
| 07/31/2023 | AVTR | Buy Now | Avantor | $20.94 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 05/11/2023 | DNA | Buy Now | Ginkgo Bioworks Holdings | $0.34 | — | — | Downgrade | Outperform → Market Perform | Get Alert |
| 09/06/2022 | SGFY | Buy Now | SIGNIFY HEALTH INC CL A | — | — | — | Downgrade | Outperform → Market Perform | Get Alert |
